Send the following on WhatsApp
Continue to ChatFinal Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast Cancer - https://avesis.gazi.edu.tr/yayin/97d08ee2-6979-4cc4-9085-913e3781f84b/final-results-of-the-randomized-phase-ii-norcap-ca223-trial-comparing-first-line-all-oral-versus-taxane-based-chemotherapy-for-her2-negative-metastatic-breast-cancer